B Mirror Repot:  Techno Drugs Limited, a publicly traded business in the pharmaceutical and chemical industries, has chosen to seek money through a bond issuance in order to lower its debt load and reorganize its financial obligations.  To strengthen its financial structure and pay back current loans, the company intends to issue a five-year coupon-bearing bond for Tk 50 crore. The business has also convened an Extraordinary General Meeting (EGM) to get shareholder approval for the change.

The information was disclosed on Sunday (May 17) through the Dhaka and Chittagong stock exchanges (DSE and CSE).

According to the company, the decision was approved at the 196th meeting of its board of directors held last Thursday. The bond issue is aimed at restructuring existing loans and improving debt management efficiency.

Of the proposed bond, 25 percent will be redeemable, while 75 percent will be convertible. This means a portion of the bond will be repaid in cash after a specified period, while the larger portion may later be converted into company shares under certain conditions.

The company believes the initiative will help reduce immediate debt pressure while strengthening its long-term capital structure.

However, the bond issue will require approval from both shareholders and the Bangladesh Securities and Exchange Commission (BSEC) before becoming effective.

The EGM has been scheduled for June 24 at 11:00am, while the record date has been fixed for June 10, 2026. Shareholders holding company shares on the record date will be eligible to participate and vote at the meeting.

Techno Drugs has appointed MTB Capital Limited as the issue manager and arranger for the proposed bond issuance.

Techno Drugs was listed on the stock market in 2024. The ‘A’ category company has a paid-up capital of Tk 131.99 crore.

As of April 30, sponsor-directors held 62.71 percent of the company’s shares, institutional investors owned 6.26 percent, and general investors held 31.03 percent.